Mads Daugaard

Mads Daugaard is a seasoned professional in the field of molecular biology and oncology, currently serving as Co-founder and President of SnapCyte Solutions Inc. and Co-founder, President, and Chief Scientific Officer at Rakovina Therapeutics. Daugaard holds positions as a Scientific Advisor at Hexamer Therapeutics, Inc. and Variational AI, in addition to serving as Associate Professor at The University of British Columbia and Head of the Molecular Pathology & Cell Imaging Laboratory at the Vancouver Prostate Centre. With extensive experience in research, Daugaard is also an editor for multiple journals, co-founder of VarCT Diagnostics, and VAR2 Pharmaceuticals, focusing on innovative tools for cancer diagnostics and therapeutics. Educational qualifications include an MSc in Biology from the University of Copenhagen and a PhD in Molecular Biology of Cancer from the Danish Research School of Molecular Cancer Research and the University of Copenhagen.